Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Faverio, P
The secondary outcomes were all-cause death, heart failure admission, admission due to any cause, composite major adverse limb events including newly diagnosed peripheral arterial disease, claudication, clinical limb ischemia, limb revascularization or amputation, hypoglycemia, diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), and infection death
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
2016 Oct;17(10):970-976
L-carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis
US$ 24.29
US$ 26.14
US$ 25.53
US$ 28.99
US$ 27.86
US$ 29.37
US$ 22.19
US$ 20.25
US$ 27.50
US$ 20.05
